Abstract: OBJECTIVE To introduce the analysis and suggestion of clinical pharmacists on drug-induced teratogenicity in pregnancy. METHODS Clinical pharmacists assessed the risk of drug used in pregnancy through showing several case studies. RESULTS Results of assessment could be supplied for clinicians to handle pregnant incidents correctly. Contents of communication could improve the recognition of drugs in pregnancy women. CONCLUSION The specialty clinic of "risk assessment and communication of drugs in pregnancy" carried out by clinical pharmacists, not only solved the difficulties of drugs used in pregnancy for doctors and patients, but also promoted the development of clinical pharmacy.